This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Seagen Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Kun-Liang Wu: Innovator in Tubulysin Preparation
Introduction
Kun-Liang Wu is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of tubulysin compounds. His innovative work has led to advancements in drug development and therapeutic applications.
Latest Patents
Kun-Liang Wu holds a patent for a process related to the preparation of tubulysins and their intermediates. The patent, titled "Process for the preparation of tubulysins and intermediates thereof," discloses improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates. This patent highlights his expertise and commitment to enhancing pharmaceutical processes.
Career Highlights
Wu is currently employed at Seagen Inc., a leading biotechnology company focused on developing innovative cancer therapies. His work at Seagen has allowed him to apply his knowledge and skills in a collaborative environment, contributing to the company's mission of improving patient outcomes.
Collaborations
Throughout his career, Kun-Liang Wu has collaborated with esteemed colleagues, including Qingwu Jin and Wendel William Doubleday. These collaborations have fostered a productive exchange of ideas and have been instrumental in advancing their shared goals in the field of drug development.
Conclusion
Kun-Liang Wu is a distinguished inventor whose work in tubulysin preparation has made a significant impact in the pharmaceutical industry. His contributions continue to influence the development of innovative therapies for cancer treatment.